- Previous Close
2.2200 - Open
2.2100 - Bid 2.2100 x --
- Ask 2.2300 x --
- Day's Range
2.1900 - 2.2900 - 52 Week Range
1.9800 - 4.7500 - Volume
10,016,600 - Avg. Volume
102,543,647 - Market Cap (intraday)
16.398B - Beta (5Y Monthly) 0.72
- PE Ratio (TTM)
-- - EPS (TTM)
-0.0900 - Earnings Date May 12, 2025 - May 16, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date Dec 28, 2021
- 1y Target Est
4.51
Hapvida Participações e Investimentos S.A., together with its subsidiaries, operates in the health sector in Brazil. The company offers health insurance plans through its clinical, outpatient, and hospital networks; and dental plans though a credentialed network. It also provides medical and paramedical, laboratory, diagnostic, imaging, and ultrasound services; health management services; and medical and hospital care services. In addition, the company organizes courses, lectures, seminars, and other events; implements health management tools; and operates hospitals, outpatient units, a children's clinic, clinical and diagnostic centers, preventive and occupational medicine spaces, and an oncology center. Further, it engages in the administration, consultancy, implementation, and commercialization of individual, family, and collective health care systems and plans; and reimbursement of medical, dental, hospital, and healthcare expenses to its beneficiaries. Hapvida Participações e Investimentos S.A. was founded in 1979 and is headquartered in Fortaleza, Brazil.
ri.hapvida.com.br--
Full Time Employees
December 31
Fiscal Year Ends
Sector
Industry
Recent News: HAPV3.SA
View MorePerformance Overview: HAPV3.SA
Trailing total returns as of 4/2/2025, which may include dividends or other distributions. Benchmark is IBOVESPA (^BVSP) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: HAPV3.SA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: HAPV3.SA
View MoreValuation Measures
Market Cap
16.47B
Enterprise Value
24.22B
Trailing P/E
--
Forward P/E
8.25
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.59
Price/Book (mrq)
0.34
Enterprise Value/Revenue
0.84
Enterprise Value/EBITDA
7.32
Financial Highlights
Profitability and Income Statement
Profit Margin
-2.25%
Return on Assets (ttm)
0.64%
Return on Equity (ttm)
-1.33%
Revenue (ttm)
28.91B
Net Income Avi to Common (ttm)
-655.27M
Diluted EPS (ttm)
-0.0900
Balance Sheet and Cash Flow
Total Cash (mrq)
8.77B
Total Debt/Equity (mrq)
34.35%
Levered Free Cash Flow (ttm)
-29.36M